Imagine the FDA suddenly declaring that a vaccine it once promoted has killed children. That’s the explosive claim now driving a radical overhaul of the FDA's vaccine approval process. Citing an un-reviewed memo alleging at least 10 child deaths from myocarditis, the agency's new chief is demanding far more robust safety data from manufacturers before any approval. This new protocol challenges decades of established science by questioning annual flu shots and the practice of giving multiple vaccines at once, prompting top experts to call the move “dangerous and irresponsible.” This seismic shift could dramatically slow the entire vaccine pipeline, delaying future life-saving immunizations and discouraging pharmaceutical innovation. For you, this could mean an end to convenient multi-vaccine appointments and much longer waits for new vaccines against future threats.